Zi Diligence Biocenter

Zi Diligence is a prominent Egyptian Contract Research Organization (CRO) established in 2014, specializing in clinical and bioanalytical services for the pharmaceutical industry. Headquartered in Cairo, the company provides a comprehensive suite of services including bioequivalence (BA/BE) studies, Phase I clinical trials, and advanced bioanalytical testing. The facility features a 48-bed clinical unit and a state-of-the-art GLP-compliant laboratory equipped with LC-MS/MS technology. Zi Diligence is accredited by the Egyptian Ministry of Health and the Gulf Cooperation Council (GCC), positioning it as a key player in the MENA region's drug development landscape. The center supports global and local pharmaceutical companies in bringing generic and novel medicines to market through rigorous adherence to GCP and GLP standards.